(Q73366498)

English

Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder

scientific article published on 01 May 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736046%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736046%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

transitional cell carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Radical cystectomy

0 references

1 reference

10.1016/S0090-4295(02)02522-0

https://api.crossref.org/works/10.1016/S0090-4295(02)02522-0

31 December 2023

Shahrokh Shariat

1

object named as

Shahrokh F Shariat

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736046%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Ben Andrews

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736046%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Shahrokh F. Shariat

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12736046

31 December 2023

Mara A. Monoski

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12736046

31 December 2023

Thomas M. Wheeler

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12736046

31 December 2023

Seth P. Lerner

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12736046

31 December 2023

Kevin M. Slawin

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12736046

31 December 2023

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736046%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

full work available at URL

https://api.elsevier.com/content/article/PII:S0090429502025220?httpAccept=text/xml

1 reference

10.1016/S0090-4295(02)02522-0

https://api.crossref.org/works/10.1016/S0090-4295(02)02522-0

31 December 2023

https://api.elsevier.com/content/article/PII:S0090429502025220?httpAccept=text/plain

1 reference

10.1016/S0090-4295(02)02522-0

https://api.crossref.org/works/10.1016/S0090-4295(02)02522-0

31 December 2023

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736046%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

61

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736046%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736046%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1053-1058

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736046%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902522-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902522-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902522-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902522-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Independent prognostic value of serum hepatocyte growth factor in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902522-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902522-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The plasminogen activation system in tumor growth, invasion, and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902522-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902522-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of urokinase-type plasminogen activator in patients with superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902522-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902522-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902522-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma Urokinase Receptor Levels in Patients With Colorectal Cancer: Relationship to Prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902522-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal screening for prostate cancer with prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902522-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The urokinase receptor. A cell surface, regulated chemokine.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902522-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasminogen activators play an essential role in extracellular-matrix invasion by lymphoblastic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902522-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Co-expression of urokinase-type plasminogen activator and its receptor in human gastric-cancer cell lines correlates with their invasiveness and tumorigenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902522-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical Cystectomy for Bladder Cancer

2

1 reference

10.1016/S0090-4295(02)02522-0

https://api.crossref.org/works/10.1016/S0090-4295(02)02522-0

31 December 2023

Prognostic significance of circulating matrix metalloproteinase-2 to tissue inhibitor of metalloproteinases-2 ratio in recurrence of urothelial cancer after complete resection

6

1 reference

10.1016/S0090-4295(02)02522-0

https://api.crossref.org/works/10.1016/S0090-4295(02)02522-0

31 December 2023

The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients

17

1 reference

10.1016/S0090-4295(02)02522-0

https://api.crossref.org/works/10.1016/S0090-4295(02)02522-0

31 December 2023

Identifiers

10.1016/S0090-4295(02)02522-0

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736046%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736046%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73366498&oldid=2041334569"